Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Felix Gerhard Maria Dietlein, M.D., Ph.D.

Concepts

Back to Details
This page shows the publications Felix Dietlein has written about Drug Administration Schedule.
Felix Dietlein
Connection Strength
0.020
Drug Administration Schedule
  1. Intermittent high-dose treatment with erlotinib enhances therapeutic efficacy in EGFR-mutant lung cancer. Oncotarget. 2015 Nov 17; 6(36):38458-68.
    View in: PubMed
    Score: 0.020
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
© 2022 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.